Posted inBiotechnology
Novel Covalent Ligands Enhance METTL5 Activity Allosterically
In a groundbreaking study published in Nature Chemical Biology, researchers have made significant strides in understanding the mechanisms of TRMT112…
Posted inBiotechnology
Engineering FNT Proteins for Bicarbonate Transport
In a groundbreaking advance poised to transform the landscape of agricultural biotechnology, researchers have unveiled the cryogenic electron microscopy (cryo-EM)…
Posted inBiotechnology
PQBP1 Y65C Mutation Drives Microcephaly and Deficits
A groundbreaking study published in Nature Communications has unveiled a highly specific mutation in the PQBP1 gene that dramatically alters…
Posted inBiotechnology
Impact of Alarming Shorter Fluoroscopy on Pediatric Studies
Radiological practices in pediatric settings have come under scrutiny in recent years, particularly regarding the exposure of young patients to…
Posted inBiotechnology
MicroRNA Imbalance in Cows During Paratuberculosis Infection
In recent advancements in the field of veterinary genomics, researchers have uncovered a significant relationship between microRNA expression and Mycobacterium…
Posted inBiotechnology
Unveiling Hub Genes for Rice’s Salt Tolerance
In the realm of agricultural science, understanding plant responses to environmental stressors is crucial for sustaining crop yields and ensuring…
Posted inBiotechnology
Revolutionary Method Predicts Drug-Target Affinity Effortlessly
In a groundbreaking development within the pharmaceutical landscape, a recent study introduces a novel approach to drug-target affinity prediction that…
Posted inBiotechnology
Chutes & Ladders—Former Roche oncology head turns to Tubulis
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please…
Posted inBiotechnology
JPM26, Day 1: Stock market titans Lilly, Nvidia expand team-up with AI co-innovation lab
The life sciences world is once again converging in San Francisco as the J.P. Morgan Healthcare Conference kicks off for…
Posted inBiotechnology
Ollin eyes phase 3 after bispecific tops Vabysmo in early-stage trial, clearing more retinal disease faster
After unsheathing just a few months ago, Ollin Biosciences’ next-gen bispecific antibody cleared more disease faster than Genentech’s Vabysmo for patients…